Breast cancer and the role of cytokines in regulating estrogen synthesis: An emerging hypothesis

Endocrine Reviews

Volumn 18, Issue 5, 1997, Pages 701-715

  Reed, M J ^a   Purohit, A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CYTOKINE; CYTOKINE RECEPTOR; DEXAMETHASONE; ESTROGEN; ESTRONE; GLUCOCORTICOID; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; PRASTERONE; SOMATOMEDIN C; SULFATASE;

AGING; BREAST CANCER; ENZYME ACTIVITY; ESTROGEN SYNTHESIS; FEMALE; HELPER CELL; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; STRESS; TUMOR IMMUNOLOGY;

EID: 0030823667     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv.18.5.0314     Document Type: Review

References (172)

1. James VHT, Reed MJ 1980 Steroid hormones and human cancer. Prog Cancer Res Ther 14:471-487
2. Bernstein L, Ross RK 1993 Endogenous hormones and breast cancer risk. Epidemiol Rev 15:48-65
3. Siiteri PK, MacDonald PC 1973 Role of extraglandular estrogen in human endocrinology. In: Greep RO, Astwood EB (eds) Handbook of Physiology. Am Physiol Soc, Washington DC, vol 11, part 1:615-629
4. Reed MJ, Button JD, Baxendale PM, James VHT, Jacobs HS, Fisher RP 1979 The conversion of androstenedione- to oestrone and production of oestrone in women with endometrial cancer. J Steroid Biochem 11:905-911
5. James VHT, McNeill JM, Lai LC, Newton CJ, Ghilchik MW, Reed MJ 1987 Aromatase activity in normal breast and breast tumour tissue: in vivo and in vitro studies. Steroids 50:269-279
6. Bradlow HL 1982 A reassessment of the role of breast tumor aromatase. Cancer Res 42 [Suppl]:3382s-3386s
7. Longcope C, Pratt JH, Schneider SH, Fineberg SE 1977 In vivo studies on the metabolism of estrogens by muscle and adipose tissue in normal males. J Clin Endocrinol Metab 45:1134-1145
8. Miller WR, Forrest APM 1974 Oestradiol synthesis from C19 steroids by human breast cancer. Br J Cancer 33:16-18
9. Tilson-Mallett N, Santner SJ, Feil PD, Santen RJ 1983 Biological significance of aromatase activity in human breast tumors. J Clin Endocrinol Metab 57:1125-1128
10. Hobkirk R 1993 Steroid sulfation. Trends Endocrinol Metab 4:69-74
11. Reed MJ, Purohit A 1993 Sulphatase inhibitors: the rationale for the development of a new endocrine therapy. Rev Endocr Relat Cancer 45:51-62
12. Reed MJ, Purohit A, Howarth NM, Potter BVL 1994 Steroid sulphatase inhibitors: a new endocrine therapy. Drugs Future 19:673-680
13. Peltoketo H, Isomaa V, Maentausta O, Vihko R 1988 Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett 239:73-77
14. Luu-The V, Labrie C, Simard J, Lachance Y, Zhao H-F, Couet J, Leblanc G, Labrie F 1989 Characterization of cDNAs for human estradiol 17β-dehydrogenase and assignment of the gene to chromosome: evidence for two mRNA species with distinct 5′-termini in human placenta. Mol Endocrinol 3:1301-1309
15. Corbin CJ, Graham-Lorence S, McPhaul M, Mason JI, Mendelson CR, Simpson ER 1988 Isolation of a full-length cDNA insert encoding human aromatase cytochrome P450 and its expression in nonsteroidogenic cells. Proc Natl Acad Sci USA 85:8948-8952
16. Chen S, Besman MJ, Sparkes RS, Zollman S, Klisak J, Mohandra T, Hall PF, Shively JE 1988 Human aromatase: cDNA cloning, Southern blot analysis and assignment of the gene to chromosome 15. DNA 7:27-38
17. Harada N 1988 Cloning of complete cDNA encoding human aromatase: immunochemical identification and sequence analysis. Biochem Biophys Res Commun 156:725-732
18. Stein C, Hille A, Seidel J, Rijnbout S, Waheed A, Schmidt B, Geuze H, Figura KV 1989 Cloning and expression of human steroid sulfatase. Membrane topology, glycosylation, and subcellular distribution in BHK-21 cells. J Biol Chem 264:13865-13872
19. Ballabio A, Parenti G, Carrozzo R, Sebastio G, Andria G, Buckle V, Frazer N, Craig I, Rocchi M, Romeo G, Tobis AC, Perisco MG 1987 Isolation and characterization of a steroid sulfatase cDNA clone: genomic deletions in patients with X-linked icthyosis. Proc Natl Acad Sci USA 84:4519-4523
20. Evans CT, Merrill JC, Corbin CJ, Saunders C, Simpson ER, Mendelson CR 1987 Regulation of estrogen biosynthesis in human adipose stromal cells. J Biol Chem 262:6914-6920
21. Poutanen M, Moncharmont B, Vihko R 1992 17β-Hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin. Cancer Res 52:290-294
22. Grodin JM, Siiteri PK, MacDonald PC 1973 Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 36:207-214
23. De Waard FW 1975 Breast cancer incidence and nutritional status with particular reference to body weight and height. Cancer Res 35:3351-3356
24. Dunn LJ, Bradbury JT 1967 Endocrine factors in endometrial carcinoma. A preliminary report. Am J Obstet Gynecol 97:465-471
25. Hemsell DL, Grodin JM, Brenner PF, Siiteri PK, MacDonald PC 1974 Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab 38:476-479
26. Cleland WH, Mendelson CR, Simpson ER 1985 Effects of aging and obesity on aromatase activity of human adipose cells. J Clin Endocrinol Metab 60:174-177
27. Folkerd EJ, Reed MJ, James VHT 1982 The in vitro conversion of androstenedione to oestrone by adipose tissue from normal women and women with endometrial cancer. In: Fioretti P, Martini L, Melis GB, Yen SSC (eds). The Menopause: Clinical, Endocrinological and Pathophysiological Aspects. Serono Symposium No. 39. Academic Press, London, pp 317-323
28. Bulun SE, Simpson ER 1994 Competitive reverse transcriptionpolymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. J Clin Endocrinol Metab 78:428-432
29. Ackerman GE, Smith ME, Mendelson CR, MacDonald PC, Simpson ER 1981 Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab 53:412-417
30. Simpson ER, Ackerman GE, Smith ME, Mendelson CR 1981 Estrogen formation in stromal cells of adipose tissue of women: induction by glucocorticoids. Proc Natl Acad Sci USA 78:5690-5694
31. Simpson ER, Merrill JC, Hollub AJ, Graham-Lorence S, Mendelson CR 1989 Regulation of estrogen biosynthesis in adipose tissue. Endocr Rev 10:136-148
32. Folkerd EJ, James VH 1983 Aromatixation of steroids in peripheral tissues. J Steroid Biochem 19:687-690
33. Reed MJ, Beranek PA, Franks S, James VH 1986 The effect of glucocorticoids on the in vivo conversion of androstenedione to oestrone. Horm Metab Res 18:635-637
34. Longcope C 1987 Peripheral aromatization: studies on controlling factors. Steroids 50:253-267
35. Noel CT, Reed MJ, Jacobs HS, James VH 1981 The plasma concentration of oestrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight. J Steroid Biochem 14:1101-1105
36. Franz C, Watson D, Longcope C 1979 Estrone sulfate and dehydroepi androsterone sulfate concentrations in normal subjects and men with cirrhosis. Steroids 34:563-573
37. Pasqualini JR, Gelly C, Nguyen B-L, Vella C 1989 Importance of estrogen sulfates in breast cancer. J Steroid Biochem 34:155-163
38. Ruder HJ, Loriaux DL, Lipsett MB 1972 Estrone sulfate: production rate and metabolism in man. J Clin Invest 51:1020-1023
39. Santner SJ, Feil PD, Santen RJ 1984 In situ estrogen production via estrone sulfatase pathway in breast tumors: relative importance vs. the aromatase pathway. J Clin Endocrinol Metab 59:29-33
40. Masamura S, Santner SJ, Santen RJ 1996 Evidence of in situ estrogen synthesis in nitrosomethylurea-induced rat mammary tumors via the enzyme estrone sulfatase. J Steroid Biochem Mol Biol 58:425-430
41. 3H-oestradiol by normal breast and breast tumour tissue in postmenopausal women. Int J Cancer 38:193-196
42. Beranek PA, Folkerd EJ, Ghilchik MW, James VHT 1984 17β Hydroxysteroid dehydrogenase activity in breast fat from women with benign and malignant breast tumours. Clin Endocrinol (Oxf) 20:205-212
43. Millington DS 1975 Determinations of hormonal steroid concentrations in biological extracts by high resolution mass fragmentography. J Steroid Biochem 6:239-245
44. Bonney RC, Reed MJ, Davidson K, Beranek PA, James VH 1983 The relationship between 17β-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue. Clin Endocrinol (Oxf) 19:727-739
45. Vermeulen A, Deslypere JP, Paridaens R, Leclerq G, Roy F, Henson JC 1986 Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur J Cancer 22:515-525
46. Recchione C, Venturelli E, Manzari A, Cavalleri A, Martinetti A, Secreto G 1995 Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissue. J Steroid Biochem Mol Biol 52:541-546
47. Thijssen JHH, Blankenstein MA 1989 Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues. Eur J Cancer Clin Oncol 25:1953-1959
48. Thijssen JHH, Blankenstein MA, Miller WR, Milewicz A 1987 Estrogens in tissues: uptake from the peripheral circulation or local production. Steroids 50:297-306
49. Blankenstein MA, Maitimu-Smeele I, Donker GH, Daroszewski J, Milewicz A, Thijssen JHH 1992 On the significance of in situ production of oestrogens in human breast cancer tissue. J Steroid Biochem Mol Biol 41:891-896
50. Fishman J, Nisselbaum JS, Menendez-Botet CJ, Schwartz MK 1977 Estrone and estradiol content in human breast tumors: relationship to estradiol receptors. J Steroid Biochem 8:893-896
51. Edery M, Goussard J, Dehennin L, Scholler R, Reiffsteck J, Drosdowsky MA 1981 Endogenous oestradiol-17β concentration in breast tumours determined by mass fragmentography and by radioimmunoassay: relationship to receptor content. Eur J Cancer 17:115-120
52. Abul-Hajj YJ 1979 Relationship between estrogen receptors, 17β hydroxysteroid dehydrogenase and estrogen content in human breast cancer. Steroids 34:217-225
53. Reed MJ, Owen AM, Lai LC, Coldham NG, Ghilchik MW, Shaikh NA, James VHT 1989 In situ oestrone synthesis in normal breast and breast tumour tissue: effect of treatment with 4-hydroxyandrostenedione. Int J Cancer 44:233-237
54. Reed MJ, Singh A, Ghilchik MW, Coldham NG, Purohit A 1991 Regulation of oestradiol 17β hydroxysteroid dehydrogenase in breast tissues: the role of growth factors. J Steroid Biochem Mol Biol 39:791-798
55. Beranek PA, Folkerd E, Newton CJ, Reed MJ, Ghilchik MW, James VHT 1985 The relationship between 17β-hydroxysteroid dehydrogenase activity and breast tumour site and size. Int J Cancer 36:685-687
56. James VHT, McNeill JM, Beranek PA, Bonney RC, Reed MJ 1986 The role of tissue steroids in regulating aromatase and oestradiol 17β-hydroxysteroid dehydrogenase activities in breast and endometrial cancer. J Steroid Biochem 25:787-790
57. Miller WR, O'Neill JS 1987 The importance of local synthesis of estrogen within the breast. Steroids 50:537-547
58. O'Neill JS, Elton RA, Miller WR 1988 Aromatase activity in adipose tissue from breast quadrants: a link with tumour site. Br Med J 296:741-743
59. Bulun SE, Price TM, Aitken J, Mahendroo MS, Simpson ER 1993 A link between breast cancer and local estrogen synthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metal 77:1622-1628
60. Purohit A, Ghilchik MW, Duncan LJ, Wang DY, Singh A, Walker MM, Reed MJ 1995 Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 80:3052-3058
61. Thijssen JHH, Blankenstein MA, Donker GH, Daroszewski J 1991 Endogenous steroid hormones and local aromatase activity in the breast. J Steroid Mol Biol 39:799-804
62. Chapman O, Purohit A, Wang DY, Ghilchik MW, Reed MJ 1995 Oestrone sulphatase activity in normal and malignant breast tissues: relationship with tumour location. Anticancer Res 15:1467-1472
63. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL 1996 Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56:4625-4629
64. Sasano H, Nagura H, Harada N, Goukon Y, Kimura M 1994 Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 25:530-535
65. Santen RJ, Martel J, Hoaland F, Naftolin F, Roa L, Harada N, Hafer L, Zaino R, Santner SJ 1994 Stromal spindle cells contain aromatase in human breast tumors. J Clin Endocrinol Metab 79:627-632
66. Esteban JM, Warsi Z, Haniu M, Hall P, Shively JE, Chen S 1992 Detection of intratumoral aromatase in breast carcinomas. Am J Pathol 140:337-343
67. Lu Q, Nakmura J, Savinov A, Yue W, Weisz J, Dabbs DJ, Wolz G, Brodie A 1996 Expression of aromatase protein and mRNA in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancer. Endocrinology 137:3061-3068
68. Singh A, Purohit A, Duncan LJ, Mokbel K, Ghilchik MW, Reed MJ 1997 Control of aromatase in breast tumours: the role of the immune system. J Steroid Biochem Mol Biol 61:185-192
69. Poutanen M, Isomaa V, Lehto V-P, Vihko R 1992 Immunological analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue. Int J Cancer 50:386-390
70. McNeill JM, Reed MJ, Beranek PA, Newton CJ, Ghilchik MW, James VHT 1986 The effect of epidermal growth factor, transforming growth factor α and breast tumour homogenates on the activity of oestradiol 17β-hydroxysteroid dehydrogenase in cultured adipose tissue. Cancer Lett 31:213-219
71. Singh A, Reed MJ, Ghilchik MW, James VHT 1989 The effect of breast tumour and normal tissue cytosols on oestradiol 17β-hydroxysteroid dehydrogenase activity. Cancer Lett 44:45-48
72. Reed MJ, Topping L, Coldham NG, Purohit A, Ghilchik MW, James VHT 1993 Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors. J Steroid Biochem Mol Biol 44:589-596
73. Dixon JM, Miller WR, Scott WN, Forrest APM 1983 The morphological basis of human breast cyst populations. Br J Surg 70: 604-606
74. Haagensen CD, Bodian C, Haagensen DE (eds) 1981 Breast Carcinoma, Risk and Detection. W.B. Saunders, Philadelphia
75. Bodian CA 1993 Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol Rev 15:177-187
76. Lai LC, Coldham NG, Islam S, Reed MJ, Ghilchik MW, James VHT 1990 Effect of breast cyst fluid as oestrogen 17-oxidoreductase activity in MCF-7 breast cancer cells. Cancer Lett 55:165-169
77. Duncan LJ, Robinson GV, Ghilchik MW, Reed MJ 1994 The effect of gross cystic disease fluid proteins on oestrogen synthesis in breast cancer cells. Endocr Relat Cancer 2:27-35
78. Reed MJ, Coldham NG, Patel SR, Ghilchik MW, James VHT 1992 Interleukin-1 and interleukin-6 in breast cyst fluid: their role in regulating aromatase activity in breast cancer cells. J Endocrinol 132:R5-R8
79. Reed MJ, Singh A, Coldham NG, Purohit A, Ghilchik MW, James VHT 1992 The regulation of estrogen synthesis in breast cells by growth factors, breast cyst fluid and breast tumour-derived factors. Cancer Detect Prev 16 [Suppl]:S61-S64
80. Singh A, Reed MJ 1991 Insulin-like growth factor I and insulin-like growth factor II stimulate oestradiol 17β-hydroxysteroid dehydrogenase activity in breast cancer cells. J Endocr 129:R5-R8
81. Singh A, Ghilchik MW, Patel SR, Blench I, Morris HR, Reed MJ 1992 Identification of albumin in breast tumour cytosol as a factor involved in the stimulation of oestradiol 17β-hydroxysteroid dehydrogenase (reductive) activity. Mol Cell Endocrinol 83:85-92
82. Singh A, Blench I, Morris HR, Savoy L-A, Reed MJ 1992 Synergistic interaction of growth factors and albumin in regulating oestrogen synthesis in breast cancer cells. Mol Cell Endocrinol 85:165-173
83. Soto T 1987 Evidence of interleukin-1-like activity associated with bovine serum albumin. J Clin Lab Immunol 24:39-43
84. Shacter E, Arzadon GK, William JA 1993 Stimulation of IL-6 and prostaglandin E2 secretion from peritoneal macrophages by polymers of albumin. Blood 82:2853-2864
85. Lai LC, Kadory S, Siraj A, Lennard TWJ 1994 Oncostatin M, interleukin-2, interleukin-6 and interleukin-8 in breast cyst fluid, Int J Cancer 59:369-372
86. Adams EF, Newton CJ, Braunsberg H, Shaikh NA, Ghilchik MW, James VHT 1988 Effect of human breast fibroblasts on growth and 17β-estradiol dehydrogenase activity of MCF-7 cells in culture. Breast Cancer Res Treat 11:165-172
87. Adams EF, Newton CJ, Tait GH, Braunsberg H, Reed MJ, James VHT 1988 Paracrine influence of human breast stromal fibroblasts on breast epithelial cells: secretion of a polypeptide which stimulates reductive 17β-oestradiol dehydrogenase activity. Int J Cancer 42:119-122
88. Adams EF, Rafferty B, White MC 1991 Interleukin 6 is secreted by breast fibroblasts and stimulates 17β-oestradiol oxidoreductase activity in MCF-7 cells: possible paracrine regulation of 17β-oestradiol levels. Int J Cancer 49:118-121
89. Duncan LJ, Coldham NG, Reed MJ 1994 The interaction of cytokines in regulating oestradiol 17β-hydroxysteroid dehydrogenase activity in MCF-7 cells. J Steroid Biochem Mol Biol 49:63-68
90. Hotamisligil GS, Shargill NS, Spiegleman BM 1993 Adipose expression of tumor necrosis factor α: direct role in obesity-linked insulin resistance. Science 259:87-91
91. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB 1995 The expression of tumor necrosis factor in human adipose tissue. J Clin Invest 95:2111-2119
92. Macdiarmid F, Wang D, Duncan LJ, Purohit A, Ghilchik MW, Reed MJ 1994 Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor α. Mol Cell Endocrinol 106:17-21
93. Purohit A, Duncan LJ, Wang DY, Coldham NG, Ghilchik MW, Reed MJ 1997 Paracrine control of oestrogen production in breast cancer. Endocr Relat Cancer 4:323-330
94. Zhao Y, Nichols JE, Bulun SE, Mendelson CR, Simpson ER 1995 Aromatase P450 gene expression in human adipose tissue. J Biol Chem 270:16449-16457
95. Schmidt M, Loffler G 1994 The human breast cancer cell line MDA-MB-231 produces an aromatase stimulating activity. Eur J Cell Biol 63:96-101
96. Chiu JJ, Sgagias MK, Cowan KH 1996 Interleukin-6 acts as a paracrine growth factor in human mammary carcinoma cell lines. Clin Cancer Res 2:215-221
97. Singh A, Purohit A, Wang DY, Duncan LJ, Ghilchik MW, Reed MJ 1995 IL-6 sR: release from MCF-7 breast cancer cells and role in regulating peripheral oestrogen synthesis. J Endocrinol 147:R9-R12
98. Rose-John S, Heinrich PC 1994 Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 300: 281-290
99. Heaney ML, Golde DW 1996 Soluble cytokine receptors. Blood 87:847-857
100. Kishimoto T, Akira S, Narazaki M, Taga T 1995 Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254
101. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T 1989 Interleukin-6 triggers the association of its receptor with a possible signal transducer protein. Cell 58:573-581
102. Novick D, Engelmann H, Wallach D, Rubinstein M 1989 Soluble cytokine receptors are present in normal human urine. J Exp Med 170:1409-1414
103. Honda M, Yamamoto S, Cheng M, Yasukawa K, Suzuki H, Saito T, Osugi Y 1992 Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 148:2175-2180
104. Mullberg J, Schooltink H, Stoyan T, Gunther M, Graeve M, Buse G, Mackiewicz A, Heinrich PC, Rose-John S 1993 The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 23:473-480
105. Mullberg J, Schooltink H, Stoyan T, Heinrich PC, Rose-John S 1992 Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor. Biochem Biophys Res Commun 189:794-800
106. Horiuchi S, Koyanagi Y, Zhou Y, Miyamoto H, Tanaka Y, Waki M, Matsumoto A, Yamamoto M, Yamamoto N 1994 Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur J Immunol 24:1945-1948
107. Mackiewicz A, Schooltink H, Heinrich PC, Rose-John S 1992 Complex of soluble human interleukin-6-receptor/IL-6 up-regulates expression of acute phase proteins. J Immunol 149:2021-2027
108. Novick D, Schulman LM, Chen L, Revel M 1992 Enhancement of IL-6 cytostatic effect on human breast carcinoma cells by IL-6 soluble receptor. Cytokine 4:6-11
109. Mackiewicz A, Wiznerowicz M, Roeb E, Kaiczewska A, Nowak J, Heinrich PC, Rose-John S 1995 Soluble interleukin-6 receptor is biologically active in vivo. Cytokine 7:142-149
110. Bauer J, Bauer TM, Kalb T, Taga T, Lengyel G, Hirano T, Kishimoto T, Acs G, Mayer L, Gerok W 1989 Regulation of interleukin 6 receptor expression in human monocytes and monocyte derived macrophages. J Exp Med 170:1537-1549
111. Rose-John S, Schooltink H, Lenz D, Hipp E, Dufhues G, Schmitz H, Schiel X, Hirano T, Kishimoto T, Heinrich PC 1990 Studies on the structure and regulation of the human interleukin-6 receptor. Eur J Biochem 190:79-83
112. Schooltink H, Schmitz-Van der Leur H, Heinrich PC, Rose-John S 1992 Upregulation of the interleukin-6 signal transduction protein (gp1301) by interleukin-6 and dexamethasone in the Hep G2 cells. FEBS Lett 297:263-265
113. Snyers L, Content J 1992 Enhancement of IL-6 receptor β chain (gp130) expression by IL-6, IL-1 and TNFα in human epithelial cells. Biochem Biophys Res Commun 185:902-908
114. Speirs V, Adams EF, Rafferty B, White MC 1993 Interactive effects of interleukin-6, 17β-estradiol and progesterone on growth and 17β-hydroxy steroid dehydrogenase activity in human breast carcinoma cells. J Steroid Biochem Mol Biol 46:11-15
115. Speirs V, Adams EF, White MC 1993 The anti-estrogen tamoxifen blocks the stimulatory effects of interleukin-6 on 17β-hydroxysteroid dehydrogenase activity in MCF-7 cells. J Steroid Biochem Mol Biol 46:605-611
116. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L 1992 The origin and function of tumour-associated macrophages. Immunol Today 13:265-270
117. Jones F, Rous P 1914 On the cause of the localization of secondary tumors at points of injury. J Exp Med 20:404-412
118. Alexander P, Murphy P, Skipper D 1988 Preferential growth of blood-borne cancer cells at sites of trauma - a growth promoting role of macrophages. Adv Exp Med Biol 233:245-251
119. Skipper D, Jeffrey MJ, Cooper AJ, Alexander P, Taylor I 1989 Enhanced growth of tumour cells in healing colonic anastomoses and laparotomy wounds. Int J Colorectal Dis 4:172-177
120. Reed MJ, Lai LC, Owen AM, Singh A, Coldham NG, Purohit A, Ghilchik MW, Shaikh NA, James VHT 1989 Effect of treatment with 4-hydroxyandrostenedione on the peripheral conversion of androstenedione to estrone and in vitro tumor aromatase activity in postmenopausal breast cancer patients. Cancer Res 49:1306-1311
121. Reed MJ 1994 The role of aromatase in breast tumors. Breast Cancer Res Treat 30:7-17
122. Reed MJ, Aherne GW, Ghilchik MW, Patel S, Chakraborty J 1991 Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues. Int J Cancer 49:562-565
123. Miller WR 1991 In vitro and in vivo effects of 4-hydroxyandrostenedione on steroid and tumour metabolism. Int Cong Symp Ser 180:45-49
124. Kelly PM, Davison RS, Bliss E, McGee JO 1988 Macrophages in human breast disease: a quantitative immunohistochemical study. Br J Cancer 57:174-177
125. Tang R, Kacinski B, Validire P, Beuvon F, Sastre X, Benoit P, Rocheforeire A, Mosseri V, Pouillart P, Schroll S 1990 Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role of hematopoietic growth factor release by tumor cells. J Cell Biochem 44:189-198
126. Reed MJ, Purohit A, Duncan LJ, Singh A, Roberts CJ, Williams GJ, Potter BVL 1995 The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumours. J Steroid Biochem Mol Biol 53:413-420
127. Baggiolini M, Dewald B, Moser B 1994 Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 55:97-179
128. Leonard EJ, Yoshimura T 1990 Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 11:97-101
129. Bokoch GM 1995 Chemoattractant signaling and leukocyte activation. Blood 86:1649-1660
130. Webb DSA, Gerrard TL 1990 IFNα and IFN-γ can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity. Proc Natl Acad Sci USA 144:3443-3648
131. Green AR, White MC, Speirs V 1996 IL-6 and IL-8 production by primary cultures of breast epithelial and stromal cells of normal and neoplastic origin. J Endocrinol 148 [Suppl]: Abstract P11
132. Berstein LM, Santen RJ, Santner SJ 1995 Three-component model of oestrogen formation and regulation of intratumoural oestrogen pool in breast neoplasms. Med Hypotheses 45:588-590
133. Chin Y, Janseens J, Vandepitte J, Vandenbrande J, Opdebeek L, Raus J 1992 Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer. Anticancer Res 12:1463-1466
134. Romagnani S 1992 Human Th1 and Th2 subsets: doubt no more. Immunol Today 12:256-257
135. Abbas AK, Murphy KM, Sher A 1996 Functional diversity of helper T lymphocytes. Nature 383:787-793
136. Daynes RA, Araneo BA, Dowell TA, Huang K, Dudley D 1990 Regulation of murine lymphokine production in vivo. J Exp Med 171:979-996
137. Daynes RA, Dudley DJ, Araneo BA 1990 Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol 20:793-803
138. Rook GAW, Hernandez-Pando R, Lightman S 1994 Hormones, peripherally activated prohormones and regulation of Th1/Th2 balance. Immunol Today 15:301-303
139. Wei J, Xu H, Davies JL, Hemmings GP 1992 Increase of plasma IL-6 concentrations with age in healthy subjects. Life Sci 51:1953-1956
140. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li G-Z, Ryu S-Y 1993 Altered regulation of IL-6 production with normal aging. J Immunol 150:5219-5230
141. Orentreich N, Brind JL, Rizer RL, Vogelman JN 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59: 551-555
142. Meikle AW, Dorchuck RW, Araneo BA, Stringham JD, Evans TG, Spruance SL, Daynes RA 1992 The presence of a specific dehydroepiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Mol Biol 42:293-304
143. Okabe T, Haji M, Takayanagi R, Adachi M, Imasaki K, Kurimoto F, Watanabe T, Nawata H 1995 Up-regulation of high-affinity dehydroepiandrosterone binding activity by dehydroepiandrosterone in activated human T lymphocytes. J Clin Endocrinol Metab 80:2993-2996
144. Hodgins M 1989 Peripheral oestrogen synthesis in man: its regulation and possible physiological significance. J Endocrinol 121:1-3
145. Christeff N, Benassayag C, Carli-Vielle C, Carli A, Nunez CA 1988 Elevated oestrogen and reduced testosterone levels in the serum of male septic shock patients. J Steroid Biochem Mol Biol 29:435-440
146. Hack CE, De Groot ER, Felt-Bersma JF, Nuijens JH, Strack Van Schijndel RJM, Eerenberg-Belmer AJM, Thijs LG, Aarden LA 1989 Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704-1710
147. Offner F, Philippe J, Vogelaers D, Colardyn F, Baele G, Baudrihaye M, Vermeulen A, Leroux-Roels G 1990 Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J Lab Clin Med 116:100-105
148. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegleman BM 1995 Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415
149. Bulbrook RD, Hayward JL 1967 Abnormal urinary steroid excretion and subsequent breast cancer. Lancet 1:519-522
150. Reed MJ 1995 The discriminant function test: a marker of Th1/Th2 cytokine secretion and breast tumour oestrogen synthesis. Mol Med Today 1:98-103
151. Kim J, Modlin RL, Moy RL, Dubinett SM, McHugh T, Nickoloff B], Uyemura K 1995 IL-10 production in cutaneous basal and squamous cell carcinomas. J Immunol 155:2240-2247
152. Chen CC, David AS, Nunnerly H, Michell M, Dawson JL, Berry H, Dobbs J, Fahy T 1995 Adverse life events and breast cancer: case-controlled study. Br Med J 311:1527-1530
153. Riley V 1981 Psychoneuroendocrine influences on immunocompetence and neoplasia. Science 212:110-1109
154. Aarstad HJ, Seljelid R 1992 Effects of stress on the growth of a fibrosarcoma in nu/nu and conventional mice. Scand J Immunol 35:209-215
155. Stewart T, Tsai S-CJ, Grayson H, Henderson R, Opelz G 1995 Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet 346:796-798
156. Leuprasitsakul P, Longcope C 1991 Aromatase activity in human adipose tissue stromal cells; the effect of fetal bovine serum fractions on dexamethasone-stimulated aromatization. J Steroid Biochem Mol Biol 39:353-357
157. Snyers L, De Wit L, Content J 1990 Glucocorticoid upregulation of high affinity interleukin-6 receptors on human epithelial cells. Proc Natl Acad Sci USA 87:2838-2842
158. Ray A, La Forge KS, Sehgal PB 1990 On the mechanism of efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer TATA box and RNA start site (Inr Motif) occlusion. Mol Cell Biol 10:5736-5746
159. Duncan LJ, Reed MJ 1995 The role and proposed mechanism by which oestradiol 17β-hydroxysteroid dehydrogenase regulates breast tumour oestrogen concentrations. J Steroid Biochem Mol Biol 55:565-572
160. Prehn RT, Lappé MA 1971 An immunostimulation theory of tumor development. Transplant Rev 7:26-54
161. Estrov Z, Samal B, Lapushin R, Kellokumpu-Lehtinen P, Sahin AA, Kurzrock R, Talpaz M, Aggarwal BB 1995 Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. J Interferon Cytokine Res 15:905-913
162. Gasean H, Anegon I, Praloran V, Naulet J, Godard A, Soulillon J-P, Jacques Y 1990 Constitutive production of human interleukin for DA cells/leukemia inhibitory factor by human cell lines derived from various tissues. J Immunol 144:2592-2598
163. Speirs V, Birch MA, Boyle-Walsh E, Green AR, Gallagher JA, White MC 1995 Interleukin-3: a putative protective factor against breast cancer which is secreted by male but not female breast fibroblasts. Int J Cancer 61:416-419
164. Santen RJ 1996 Estrogen synthesis inhibitors for breast cancer: an introductory overview. Endocr Relat Cancer 3:1-8
165. Miller WR 1996 Aromatase inhibitors - where are we now? Br J Cancer 73:415-417
166. Luu-The V, Zhang Y, Poirier D, Labrie F 1995 Characteristics of human Types 1, 2 and 3 17β-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition. J Steroid Biochem Mol Biol 55:581-587
167. Woo LWL, Purohit A, Reed MJ, Potter BVL 1996 Active sitedirected inhibition of estrone sulfatase by non steroidal Coumarin sulfamates. J Med Chem 39:1349-1351
168. Castiglione-Gertsch M 1996 New aromatase inhibitors: more selectivity, less toxicity, unfortunately, the same activity. Eur J Cancer 32A:393-395
169. Jonat W, Howell A, Blomqvist C, Eiermann W, Winblad G, Tyrrell C, Mauriac L, Roche H, Lundgren S, Hellmund R, Azab M 1996 A randomised trial comparing two doses of the new selective aromatase inhibitor Anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer Eur J Cancer 32A:404-412
170. Klein B, Brailly H 1995 Cytokine-binding proteins: stimulating antagonists. Immunol Today 16:216-220
171. Loria RM, Padgett DA 1992 Androstendiol regulates systemic resistance against lethal infections in mice. Arch Virol 127:103-115
172. Padgett DA, Loria RM 1994 In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol and androstenetriol. J Immunol 153:1544-1552